CDKN2A and cancer: The higher cancer cell specificity of the ERE73s-ARF (−13) is primarily a reflection of the relatively low activity of the ERE73s-ARF constructs in normal HFFs, compared to the hTERT, ARF, or E2WT-ARF (−13) promoters (Figure 1D).